Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington’s Disease and Tardive Dyskinesia

Samuel Frank,1 Aljoharah Alakkas2 1Department of Neurology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA; 2Department of Neurology, National Neuroscience Institute, King Fahad Medical City, Riyadh, K.S.ACorrespondence: Samuel Frank, Department of Neurology, Beth Israe...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Frank S, Alakkas A
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Dove Medical Press 2023-12-01
Schriftenreihe:	Therapeutics and Clinical Risk Management
Schlagworte:	chorea tardive dyskinesia hyperkinetic movement disorders vmat2 inhibitors
Online-Zugang:	https://www.dovepress.com/clinical-utility-of-deutetrabenazine-as-a-treatment-option-for-chorea--peer-reviewed-fulltext-article-TCRM
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!